For the Quarter Ending June 2026
Potassium Clavulanate Prices in North America
- In USA, the Potassium Clavulanate Price Index rose by 17.02% quarter-over-quarter, driven by feedstock, freight.
- The average Potassium Clavulanate price for the quarter was approximately USD 75665.00/MT, reflecting logistics pressures.
- Potassium Clavulanate Spot Price mirrored stronger origin offers while the Price Index signalled restrained buying.
- Potassium Clavulanate Price Forecast shows softening in June then modest recovery as procurement normalises thereafter.
- Potassium Clavulanate Production Cost Trend eased as lower caustic potash prices offset higher refrigerated freight.
- Potassium Clavulanate Demand Outlook remains steady with formulators maintaining production while rebuilding safety inventories seasonally.
- Potassium Clavulanate Price Index eased in June as comfortable distributor inventories tempered buying despite freight.
- Exporters continued shipments without reported curbs, supporting contractual volumes while distributors gradually rebuilt safety inventories.
Why did the price of Potassium Clavulanate change in June 2026 in North America?
- Tight export availability and regulatory audits limited supply into the United States, forcing higher bids.
- Declining caustic potash eased costs while higher refrigerated freight increased landed import costs for buyers.
- Comfortable finished-dose inventories and subdued tendering reduced immediate procurement, applying mild downward pressure on imports.
Potassium Clavulanate Prices in APAC
- In China, the Potassium Clavulanate Price Index rose by 17.03% quarter-over-quarter, driven by feedstock inflation.
- The average Potassium Clavulanate price for the quarter was approximately USD 74,866.67/MT, FOB Shanghai basis.
- Potassium Clavulanate Spot Price tightened in April after inspections trimmed run-rates, supporting elevated supplier offers.
- Potassium Clavulanate Price Forecast signals June easing as inventories rebuild and buyers reduce immediate procurement.
- Potassium Clavulanate Production Cost Trend improved slightly as Caustic Potash softened, relieving manufacturing expense pressures.
- Potassium Clavulanate Demand Outlook remains steady with hospital tenders and export inquiries supporting baseline consumption.
- Potassium Clavulanate Price Index eased in June as producers maintained rates and released modest volumes.
- Inventories remained thin with two weeks cover, so any production hiccup tightened offers and exports.
Why did the price of Potassium Clavulanate change in June 2026 in APAC?
- Supply curbs from environmental inspections reduced fermentation run-rates, limiting effective output and tightening exportable volumes.
- Feedstock pressures, especially Caustic Potash, raised manufacturing costs, supporting firmer offers earlier this quarter overall.
- Maritime rerouting due to regional conflict lengthened voyages, increasing freight and insurance costs for exports.
India
- In India, the Potassium Clavulanate Price Index rose by 17.07% quarter-over-quarter, reflecting higher landed import costs.
- Ample Chinese export availability softened the Potassium Clavulanate Spot Price, easing the domestic Price Index downward pressure.
Potassium Clavulanate Prices in Europe
- In Germany, the Potassium Clavulanate Price Index rose by 17.0% quarter-over-quarter, driven by firmer Asian export offers.
- The average Potassium Clavulanate price for the quarter was approximately USD 75646.67/MT, CFR Hamburg landed costs.
- Port congestion and extended transit increased landed costs, pressuring Potassium Clavulanate Spot Price despite steady import volumes.
- German distributors reported three-week inventory cover, influencing Potassium Clavulanate Price Index movement and buying patterns.
- Lower Caustic Potash costs moderated Potassium Clavulanate Production Cost Trend, allowing exporters to offer more competitive quotations.
- Near-term Potassium Clavulanate Demand Outlook remains stable across formulation and hospital procurement cycles, supporting baseline buying.
- Analysts adjusted the Potassium Clavulanate Price Forecast modestly, anticipating slight recovery as inventories normalize and buying resumes.
- Export availability from China improved, shipping delays persisted, prompting cautious procurement and weighing on short-term market sentiment.
Why did the price of Potassium Clavulanate change in June 2026 in Europe?
- Tighter Asian export offers and higher upstream costs reduced availability, lifting landed CFR Hamburg prices.
- Container allocation shortages, longer transit times increased lead times, raising logistical premiums and delivery risk.
- Relaxed seasonal demand and inventory drawdowns limited buying, contributing to softer Potassium Clavulanate Price Index.
For the Quarter Ending March 2026
Potassium Clavulanate Prices in APAC
- In China, the Potassium Clavulanate Price Index rose by 4.54% quarter-over-quarter, reflecting a modest cost push.
- The average Potassium Clavulanate price for the quarter was approximately USD 63,970/MT, reflecting export-led restocking demand.
- Domestic output tightness reduced spot availability, pushing Potassium Clavulanate Spot Price higher in export hubs.
- Rising feedstock costs drove the Potassium Clavulanate Production Cost Trend upward, squeezing manufacturers' crystallization margins.
- Forward bookings and export demand informed the Potassium Clavulanate Price Forecast, indicating cautious near-term firmness.
- Hospital procurement cycles and reformulation trends supported the Potassium Clavulanate Demand Outlook for sustained consumption.
- Inventory cover tightened to three weeks, maintaining Potassium Clavulanate Price Index strength during constrained supply.
- Producers prioritized confirmed export orders, reflecting disciplined inventory management and steady operational utilization near-term patterns
Why did the price of Potassium Clavulanate change in March 2026 in APAC?
- Feedstock Caustic Potash surged, raising conversion expenses and pushing sellers to pass through higher costs.
- Environmental audits curtailed fermentation runs, reducing spot availability and shortening inventory buffers at coastal warehouses.
- Robust domestic hospital procurement and redirected export enquiries from Europe elevated demand for Chinese supplies
Potassium Clavulanate Prices in Europe
- In Germany, the Potassium Clavulanate Price Index rose by 5.49% quarter-over-quarter, driven by FOB offers.
- The average Potassium Clavulanate price for the quarter was approximately USD 64668.33/MT, weighted monthly calculation
- Potassium Clavulanate Spot Price strengthened in March as allocations and caustic potash costs persisted abroad
- Exporters maintained disciplined CFR offers; Potassium Clavulanate Price Forecast suggests modest gains amid restocking dynamics.
- Caustic Potash elevated Potassium Clavulanate Production Cost Trend, raising neutralization and spray-drying expenses for manufacturers.
- Potassium Clavulanate Demand Outlook remains stable with hospital tender restocking supporting purchases through early spring.
- Inventory levels at distributors were comfortable, Potassium Clavulanate Price Index remained firm due to spot availability.
- Logistics pressures and higher ocean rates increased landed costs, supporting Potassium Clavulanate Price Index resilience.
Why did the price of Potassium Clavulanate change in March 2026 in Europe?
- Stronger Asian FOB offers and higher Caustic Potash feedstock prices pushed landed import parity upward.
- German hospital tender restocking increased buying interest, absorbing available spot volumes despite steady retail demand.
- Elevated ocean freight and compliance costs added to conversion and logistics expenses, tightening supply economics.
Potassium Clavulanate Prices in North America
- In the USA, the Potassium Clavulanate Price Index rose by 5.48% quarter-over-quarter, from feedstock pressures.
- The average Potassium Clavulanate price for the quarter was approximately USD 64657.67/MT, CFR Los Angeles.
- Potassium Clavulanate Spot Price tightened as Price Index rose, reflecting higher freight and feedstock costs.
- Potassium Clavulanate Price Forecast points to moderate further gains as restocking intersects constrained spot availability.
- Potassium Clavulanate Production Cost Trend rose on Caustic Potash and refrigerated freight, pressuring conversion costs.
- Potassium Clavulanate Demand Outlook remains firm as prescription volumes steady and substitute shortages divert orders.
- Potassium Clavulanate Price Index reflected exporter discipline, thin port stocks, and longer reefer lead times.
- Exporters prioritized regional sales, limiting spot allocations and supporting firmer CFR offers into Los Angeles.
Why did the price of Potassium Clavulanate change in March 2026 in North America?
- Upstream Caustic Potash inflation sharply increased Chinese conversion costs, passing through to U.S. landed prices.
- Shanghai to Houston reefer freight rises, slot tightness lengthened lead times, adding inventory carrying costs.
- Steady prescription demand absorbed higher landed costs without provoking aggressive procurement or volume pull-forward.
For the Quarter Ending December 2025
North America
• In the USA, the Potassium Clavulanate Price Index fell by 0.41% quarter-over-quarter; freight reductions outweighed tariffs.
• The average Potassium Clavulanate price for the quarter was USD 85095.67/MT, reflecting landed-costs.
• Potassium Clavulanate Spot Price softened as China shipments and lower China-US freight eroded landed costs.
• Potassium Clavulanate Price Forecast anticipates modest gains early in the year as manufacturers replenish inventories.
• Potassium Clavulanate Production Cost Trend remained pressured by elevated caustic potash feedstock and compliance overheads.
• Potassium Clavulanate Demand Outlook is steady, driven by antibiotic shortages and formulators maintaining procurement and stockpiles.
• Inventories and export demand influenced the Potassium Clavulanate Price Index, tempering upside despite Indian controls.
• Chinese plant uptime sustained exports, Indian licences constrained volumes, moderating offers, and equilibrium.
Why did the price of Potassium Clavulanate change in December 2025 in North America?
• Lower China-to-US freight rates reduced landed costs, directly easing CFR offers during December's month-end adjustments.
• Indian export licensing tightened supply, but abundant Chinese shipments prevented acute shortages, muting upward price pressure.
• Steady winter antibiotic demand and sufficient importer coverage limited spot buying intensity, allowing offers to edge lower.
APAC
• In China, the Potassium Clavulanate Price Index fell by 0.4% quarter-over-quarter, reflecting elevated feedstock costs.
• The average Potassium Clavulanate price for the quarter was approximately USD 61193.33/MT, slightly stabilizing offers.
• Potassium Clavulanate Spot Price eased as inventories rose, and buyers constrained by tender ceilings limited purchases.
• Potassium Clavulanate Price Forecast indicates recovery into early 2026, driven by restocking and seasonal prescriptions.
• Potassium Clavulanate Production Cost Trend remained pressured by caustic potash inflation despite stable electricity tariffs.
• Potassium Clavulanate Demand Outlook is cautious with tender ceilings, selective international orders, and domestic procurement.
• Elevated year-end output increased bonded warehouse stocks, pressuring the Potassium Clavulanate Price Index slightly lower.
• Producers maintained high fermentation utilization; inventories grew, keeping sellers competitive on FOB despite muted demand.
Why did the price of Potassium Clavulanate change in December 2025 in APAC?
• High year-end domestic output increased available tonnes, overpowering mild respiratory-season demand and leaving stocks elevated.
• Caustic potash costs remained stable, keeping production costs neutral while exporters built inventories at warehouses.
• National bulk tender price ceilings and restrained international enquiries capped procurement, preventing FOB pricing upside.
Europe
• In Germany, the Potassium Clavulanate Price Index fell by 0.42% quarter-over-quarter, reflecting muted buying pressures.
• The average Potassium Clavulanate price for the quarter was approximately USD 85087.00/MT, CIF Hamburg basis.
• Potassium Clavulanate Spot Price remained pressured by abundant imports and balanced northern port inventories overall.
• Potassium Clavulanate Price Forecast indicates modest recovery early next year as buyers replenish inventories cautiously.
• Potassium Clavulanate Production Cost Trend was neutral as caustic potash and fermentation feedstocks remained unchanged.
• Potassium Clavulanate Demand Outlook stayed steady with hospital tender timing and stewardship measures tempering offtake.
• Price Index movements reflected exporters protecting margins while German buyers delayed year-end orders, softening offers.
• Potassium Clavulanate Price Index stability benefited from streamlined Hamburg clearance and steady freight, maintaining supply.
Why did the price of Potassium Clavulanate change in December 2025 in Europe?
• Comfortable import volumes from China and India boosted port stocks, limiting sellers' leverage and price upside.
• Stable caustic potash and fermentation feedstock costs left conversion expenses subdued, constraining upward price momentum.
• Digitalized Hamburg clearance and calm freight lanes expedited arrivals while domestic demand remained seasonally restrained.
For the Quarter Ending September 2025
North America
• In USA, the Potassium Clavulanate Price Index fell by 10.27% quarter-over-quarter, reflecting global oversupply and destocking.
• The average Potassium Clavulanate price for the quarter was approximately USD 85450.00/MT, CFR Los Angeles.
• Potassium Clavulanate Spot Price weakened as Asian exporters discounted amid export volumes and muted demand.
• Potassium Clavulanate Price Forecast anticipates near-term softness before stabilization as inventories gradually normalize and restocking.
• Potassium Clavulanate Production Cost Trend shows upward pressure from drayage increases on landed CFR basis.
• Demand Outlook stays muted as pharmaceutical buyers draw down stocks and further delay spot purchases.
• Elevated inventories pressured the Price Index, while logistics improvements allowed limited recovery broadly in offers.
• Chinese export competitiveness continued pressuring offers, though temporary plant turnarounds tightened supply to US markets.
Why did the price of Potassium Clavulanate change in September 2025 in North America?
• China and India export surges created inventory gluts, prompting aggressive discounting into United States markets.
• US manufacturers pre-stocked earlier, reducing fresh procurement and thereby diminishing immediate spot market demand significantly.
• Tariff uncertainty and logistics volatility delayed orders, suppressing spot activity despite occasional freight-driven cost increases.
APAC
• In China, the Potassium Clavulanate Price Index fell by 10.2384% quarter-over-quarter, driven by oversupply and destocking.
• The average Potassium Clavulanate price for the quarter was approximately USD 85333.33/MT FOB Shanghai sales.
• Potassium Clavulanate Spot Price showed short-term spikes amid logistical disruptions and temporary production maintenance constraints.
• Potassium Clavulanate Price Forecast indicates modest fluctuations with limited upside while inventories remain elevated regionally.
• Potassium Clavulanate Production Cost Trend reflected lower raw material prices, compressing producer margins and limiting cuts.
• Potassium Clavulanate Demand Outlook remains subdued due to weak pharmaceutical procurement and export restrictions reducing demand.
• Potassium Clavulanate Price Index weakness reflected aggressive domestic competition, maintenance-induced supply swings, and destocking-driven discounting.
• Inventory accumulation and tapered export flows pressured margins, while selective restocking could stabilise regional price trajectories.
Why did the price of Potassium Clavulanate change in September 2025 in APAC?
• Supply overshang from aggressive destocking and resumed output created downward pressure despite some maintenance-related shortages.
• Logistics disruptions and port congestion temporarily tightened availability, causing upward moves in FOB supply corridors.
• Weaker domestic procurement and soaring inventories combined with export barriers suppressed demand, prolonging price weakness.
Europe
• In Germany, the Potassium Clavulanate Price Index fell by 10.22% quarter-over-quarter in Q3 2025, reflecting abundant inventories.
• The average Potassium Clavulanate price for the quarter was approximately USD 85443.33/MT based on reported CFR Hamburg transactions.
• Potassium Clavulanate Spot Price softened as distributors aggressively cleared stock amid muted domestic procurement and euro appreciation.
• Potassium Clavulanate Price Forecast indicates modest downward pressure through year end as imports remain elevated from China.
• Potassium Clavulanate Production Cost Trend eased with lower energy and feedstock inputs, supporting competitive exporter pricing.
• Potassium Clavulanate Demand Outlook remains steady from pharmaceutical formulators, hospitals and outpatient units supporting baseline consumption.
• Potassium Clavulanate Price Index volatility increased owing to periodic shipping delays, port congestion, and intermittent demurrage fees.
• Inventory gluts and cautious procurement strategies pressured German domestic prices despite steady sectoral off-take and strategic replenishment.
Why did the price of Potassium Clavulanate change in September 2025 in Europe?
• Abundant inventories among German distributors reduced transactional urgency and depressed spot prices across the quarter ending September.
• Elevated import volumes from China combined with euro appreciation amplified downward pressure on local Potassium Clavulanate pricing.
• Shipping disruptions and port congestion intermittently tightened supply margins but overall muted demand sustained the bearish price trend.
